GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seneca Biopharma Inc (STU:7NS2) » Definitions » Cyclically Adjusted PB Ratio

Seneca Biopharma (STU:7NS2) Cyclically Adjusted PB Ratio : (As of May. 18, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Seneca Biopharma Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Seneca Biopharma Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Seneca Biopharma's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seneca Biopharma Cyclically Adjusted PB Ratio Chart

Seneca Biopharma Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Seneca Biopharma Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Seneca Biopharma's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Seneca Biopharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seneca Biopharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seneca Biopharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Seneca Biopharma's Cyclically Adjusted PB Ratio falls into.



Seneca Biopharma Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Seneca Biopharma's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2020 is calculated as:

For example, Seneca Biopharma's adjusted Book Value per Share data for the three months ended in Dec. 2020 was:

Adj_Book=Book Value per Share/CPI of Dec. 2020 (Change)*Current CPI (Dec. 2020)
=0.464/109.8968*109.8968
=0.464

Current CPI (Dec. 2020) = 109.8968.

Seneca Biopharma Quarterly Data

Book Value per Share CPI Adj_Book
201103 33.254 94.283 38.761
201106 23.322 95.235 26.913
201109 15.152 95.727 17.395
201112 6.740 95.213 7.779
201203 16.506 96.783 18.743
201206 9.531 96.819 10.818
201209 27.008 97.633 30.400
201212 20.258 96.871 22.982
201303 16.613 98.209 18.590
201306 12.318 98.518 13.741
201309 20.973 98.790 23.331
201312 20.513 98.326 22.927
201403 58.326 99.695 64.295
201406 52.951 100.560 57.868
201409 48.394 100.428 52.957
201412 42.559 99.070 47.210
201503 51.489 99.621 56.800
201506 36.695 100.684 40.053
201509 22.472 100.392 24.600
201512 12.886 99.792 14.191
201603 -0.429 100.470 -0.469
201606 1.686 101.688 1.822
201609 -7.635 101.861 -8.237
201612 19.457 101.863 20.992
201703 15.357 102.862 16.407
201706 11.385 103.349 12.106
201709 12.802 104.136 13.510
201712 9.482 104.011 10.019
201803 7.058 105.290 7.367
201806 6.962 106.317 7.196
201809 5.038 106.507 5.198
201812 5.832 105.998 6.047
201903 3.172 107.251 3.250
201906 1.730 108.070 1.759
201909 2.268 108.329 2.301
201912 1.193 108.420 1.209
202003 0.958 108.902 0.967
202006 0.833 108.767 0.842
202009 0.693 109.815 0.694
202012 0.464 109.897 0.464

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Seneca Biopharma  (STU:7NS2) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Seneca Biopharma Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Seneca Biopharma's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Seneca Biopharma (STU:7NS2) Business Description

Traded in Other Exchanges
N/A
Address
20271 Goldenrod Lane, Suite 2024, Germantown, MD, USA, 20876
Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need. It is focused on the research and development of nervous system therapies based on proprietary human neural stem cells and small molecule compounds.

Seneca Biopharma (STU:7NS2) Headlines

No Headlines